Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Médicaments En Vente Libre > OTC Pharmaceuticals in Brazil
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Médicaments En Vente Libre > Etude de marché sectorielle
 OTC Pharmaceuticals in Brazil
€ 200,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Janvier 2008
Taille du document :
35
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Plus d'information ?
+33 437 37 1637
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
US Gastrointestinal Remedies 2004
12 pages | Novembre 2004 |
Snapdata's US Gastrointestinal Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US gastrointestinal
240,00 €
 
 
US Antacids 2004
16 pages | Juillet 2004 |
Snapdata's US Antacids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antacid market, and covers antacid
240,00 €
 
 
US Lip Remedies 2004
13 pages | Juillet 2004 |
Snapdata's US Lip Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US lip remedy market, and covers
240,00 €
 
 
US Acne Treatments 2004
14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US acne treatments market.
240,00 €
 
 
US External Analgesics 2004
16 pages | Juillet 2004 |
Snapdata's US External Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US external analgesic mark
240,00 €
 
 
US Laxatives 2004
12 pages | Novembre 2004 |
Snapdata's US Laxatives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US laxative market, and covers laxat
240,00 €
 
 
US Smoking Cessation Aids 2004
13 pages | Juillet 2004 |
Snapdata's US Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US smoking cessation ai
240,00 €
 
 
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand
2 443,75 €
 
 
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo
2 443,75 €
 
 
US Vitamins & Minerals 2004
13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US vitamin and mineral mar
240,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 OTC Pharmaceuticals in Brazil

Datamonitor's OTC Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.


 

TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 16
6.5 Substitutes 18
6.6 Rivalry 19
CHAPTER 7 Leading Companies 20
7.1 Pfizer Inc 20
7.2 GlaxoSmithKline Plc 23
7.3 Novartis AG 27
CHAPTER 8 Distribution 30
CHAPTER 9 Market Forecasts 31
9.1 Market Value Forecast 31
CHAPTER 10 Macroeconomic Indicators 32
CHAPTER 11 Appendix 34
11.1 Methodology 34
11.2 Industry Associations 35
11.3 Related Datamonitor Research 35

LIST OF TABLES
Table 1: Brazil OTC Pharmaceuticals Market Value: $ billion, 2003-2007 9
Table 2: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Pfizer Inc 20
Table 6: Key Financials: Pfizer Inc 22
Table 7: Key Facts: GlaxoSmithKline Plc 23
Table 8: Key Financials: GlaxoSmithKline Plc 26
Table 9: Key Facts: Novartis AG 27
Table 10: Key Financials: Novartis AG 29
Table 11: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2007 30
Table 12: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 31
Table 13: Brazil Size of Population (million) , 2003-2007 32
Table 14: Brazil GDP (Constant 2000 Prices, $ billion), 2003-2007 32
Table 15: Brazil Inflation, 2003-2007 32
Table 16: Brazil Exchange Rate, 2003 33



New Search:

PPLSEN